🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The purpose of this study is: To assess whether there are differences in a...
Status
Completed
Location
Health Protection Agency
Start Date
2008-02
Trial ID
NCT00625677
Treatments Being Tested
This is a randomized double-blind controlled study and was performed to com...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02808637
This multicentre, parallel group, block randomised clinical trial aims to i...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-08
Trial ID
NCT02482636
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested